MedTrace Logo

Observational Longitudinal Study in Children Affected by Idiopathic Growth Hormone Deficiency (GHD)

NCT02507245 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 48

Last updated 2015-07-23

No results posted yet for this study

Summary

The aim of this study is to assess the developmental patterns of lung function in children affected by growth hormone deficiency after one year of GH therapy.The assessment by specific questionnaires of quality of life and of parental stress index.Parameters will be evaluated at the time of the diagnosis and after 12 months of GH therapy.

Conditions

  • Growth Hormone Deficiency

Interventions

DRUG

Growth Hormone-Releasing Hormone

From Baseline Visit (T0) to 6th Month Visit 0,025 mg/kg Growth Hormone/die. From 6th Month Visit to 12th Month Visit 0,030 mg/Kg Growth Hormone/die.

Sponsors & Collaborators

  • Stefania La Grutta, MD

    lead OTHER

Eligibility

Min Age
5 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-04-30
Completion
2015-05-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02507245 on ClinicalTrials.gov